Par Drugs (India) Technical Analysis
| PAR Stock | 115.95 5.94 4.87% |
As of the 26th of February, Par Drugs holds the Risk Adjusted Performance of (0.17), coefficient of variation of (416.96), and Variance of 27.6. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Par Drugs, as well as the relationship between them. Please check Par Drugs And information ratio, and the relationship between the coefficient of variation and value at risk to decide if Par Drugs And is priced some-what accurately, providing market reflects its current price of 115.95 per share.
Par Drugs Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Par, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ParPar |
Par Drugs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Par Drugs And Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Par Drugs And volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Par Drugs And Trend Analysis
Use this graph to draw trend lines for Par Drugs And. You can use it to identify possible trend reversals for Par Drugs as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Par Drugs price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Par Drugs Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Par Drugs And applied against its price change over selected period. The best fit line has a slop of 1.77 , which may suggest that Par Drugs And market price will keep on failing further. It has 122 observation points and a regression sum of squares at 119077.13, which is the sum of squared deviations for the predicted Par Drugs price change compared to its average price change.About Par Drugs Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Par Drugs And on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Par Drugs And based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Par Drugs And price pattern first instead of the macroeconomic environment surrounding Par Drugs And. By analyzing Par Drugs's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Par Drugs's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Par Drugs specific price patterns or momentum indicators. Please read more on our technical analysis page.
Par Drugs February 26, 2025 Technical Indicators
Most technical analysis of Par help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Par from various momentum indicators to cycle indicators. When you analyze Par charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.17) | |||
| Market Risk Adjusted Performance | (1.60) | |||
| Mean Deviation | 3.25 | |||
| Coefficient Of Variation | (416.96) | |||
| Standard Deviation | 5.25 | |||
| Variance | 27.6 | |||
| Information Ratio | (0.24) | |||
| Jensen Alpha | (1.26) | |||
| Total Risk Alpha | (1.22) | |||
| Treynor Ratio | (1.61) | |||
| Maximum Drawdown | 39.98 | |||
| Value At Risk | (5.46) | |||
| Potential Upside | 5.38 | |||
| Skewness | (0.14) | |||
| Kurtosis | 7.24 |
Complementary Tools for Par Stock analysis
When running Par Drugs' price analysis, check to measure Par Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Par Drugs is operating at the current time. Most of Par Drugs' value examination focuses on studying past and present price action to predict the probability of Par Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Par Drugs' price. Additionally, you may evaluate how the addition of Par Drugs to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |